| Literature DB >> 28217113 |
Pascale Flury1, Pilar Vesga1, Maria Péchy-Tarr2, Nora Aellen1, Francesca Dennert1, Nicolas Hofer1, Karent P Kupferschmied2, Peter Kupferschmied2, Zane Metla3, Zongwang Ma4, Sandra Siegfried1, Sandra de Weert5, Guido Bloemberg5, Monica Höfte4, Christoph J Keel2, Monika Maurhofer1.
Abstract
Particular groups of plant-beneficial fluorescent pseudomonads are not only root colonizers that provide plant disease suppression, but in addition are able to infect and kill insect larvae. The mechanisms by which the bacteria manage to infest this alternative host, to overcome its immune system, and to ultimately kill the insect are still largely unknown. However, the investigation of the few virulence factors discovered so far, points to a highly multifactorial nature of insecticidal activity. Antimicrobial compounds produced by fluorescent pseudomonads are effective weapons against a vast diversity of organisms such as fungi, oomycetes, nematodes, and protozoa. Here, we investigated whether these compounds also contribute to insecticidal activity. We tested mutants of the highly insecticidal strains Pseudomonas protegens CHA0, Pseudomonas chlororaphis PCL1391, and Pseudomonas sp. CMR12a, defective for individual or multiple antimicrobial compounds, for injectable and oral activity against lepidopteran insect larvae. Moreover, we studied expression of biosynthesis genes for these antimicrobial compounds for the first time in insects. Our survey revealed that hydrogen cyanide and different types of cyclic lipopeptides contribute to insecticidal activity. Hydrogen cyanide was essential to full virulence of CHA0 and PCL1391 directly injected into the hemolymph. The cyclic lipopeptide orfamide produced by CHA0 and CMR12a was mainly important in oral infections. Mutants of CMR12a and PCL1391 impaired in the production of the cyclic lipopeptides sessilin and clp1391, respectively, showed reduced virulence in injection and feeding experiments. Although virulence of mutants lacking one or several of the other antimicrobial compounds, i.e., 2,4-diacetylphloroglucinol, phenazines, pyrrolnitrin, or pyoluteorin, was not reduced, these metabolites might still play a role in an insect background since all investigated biosynthetic genes for antimicrobial compounds of strain CHA0 were expressed at some point during insect infection. In summary, our study identified new factors contributing to insecticidal activity and extends the diverse functions of antimicrobial compounds produced by fluorescent pseudomonads from the plant environment to the insect host.Entities:
Keywords: Gac regulatory system; Pseudomonas chlororaphis; Pseudomonas fluorescens; Pseudomonas protegens; insecticidal activity; orfamide; secondary metabolites; sessilin
Year: 2017 PMID: 28217113 PMCID: PMC5289993 DOI: 10.3389/fmicb.2017.00100
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains used in this study.
| CHA0 | Wild type, isolated from tobacco roots | Stutz et al., | |
| CHA19 | Δ | GacS sensor | Zuber et al., |
| CHA89 | GacA response regulator | Laville et al., | |
| CHA400 | Pyoverdine (Pvd) | Keel et al., | |
| CHA805 | Nonpolar | Protease AprA (AprA) | Siddiqui et al., |
| CHA805-g | CHA805::attTn | AprA | This study |
| CHA1151 | Δ | Fit toxin (Fit) | Péchy-Tarr et al., |
| CHA1196 | Δ | Glucose dehydrogenase (Gcd) | De Werra et al., |
| CHA1197 | Δ | Gluconate dehydrogenase (Gad) | De Werra et al., |
| CHA1241 | Δ | 2,4-Diacetylphloroglucinol (Phl) | This study |
| CHA1281 | Δ | Fit toxin and GacA | Ruffner et al., |
| CHA5091 | Δ | Pyrrolnitrin (Prn) | This study |
| CHA5092 | Δ | Pyoluteorin (Plt) | This study |
| CHA5098 | Δ | Phl/Prn/Plt | This study |
| CHA5101 | Δ | Orfamide (Ofa) | This study |
| CHA5103 | Δ | Hydrogen cyanide (Hcn) | This study |
| CHA5118 | Δ | Phl/Prn/Plt/Hcn/Ofa | This study |
| PCL1391 | Wild type, isolated from tomato roots | Chin-A-Woeng et al., | |
| PCL1113 | Phenazine-1-carboxylic acid and phenazine-1-carboxamide (Phz) | Chin-A-Woeng et al., | |
| PCL1123 | GacS | This study | |
| PCL1832 | Clp1391 | This study | |
| PCL5103 | Δ | Hcn | This study |
| CMR12a | Wild type, isolated from cocoyam roots | Perneel et al., | |
| CMR12a-ΔPhz | Δ | Phenazine (Phz) | D'aes et al., |
| CMR12a-Clp1 | Sessilin (Ses) | D'aes et al., | |
| CMR12a-ΔPhz-Clp1 | Δ | Phz/Ses | D'aes et al., |
| CMR12a-ΔClp2 | Δ | Orfamide (Ofa) | D'aes et al., |
| CMR12a-ΔPhz-ΔClp2 | Δ | Phz/Ofa | D'aes et al., |
| CMR12a-ΔClp2-Clp1 | Δ | Ofa/Ses | D'aes et al., |
| CMR12a-ΔPhz-ΔClp2-Clp1 | Δ | Phz/Ofa/Ses | D'aes et al., |
| DH5α | Sambrook and Russel, | ||
| S17-1/λpir | Simon et al., | ||
Gm.
Lethal time 50 (LT.
| CHA0 | Wild type | 29.1 (28.8; 29.4) | 32.9 (32.5; 33.3) | 33.8 (33.4; 34.1) | 33.7 (33.3; 34.1) |
| CHA1151 | Fit− | 30.6 (30.1; 31.1) | 32.8 (32.5; 33.2) | 34.6 (34.2; 35.0) | 36.3 (35.8; 36.7) |
| CHA1281 | GacA−Fit− | 31.8 (31.3; 32.2) | 35.3 (34.6; 35.9) | 34.1 (33.7; 34.5) | 36.8 (36.3; 37.3) |
| CHA400 | Pvd− | 33.0 (32.4; 33.6) | 34.1 (33.6; 34.5) | ||
| CHA1196 | Gcd− | 34.7 (34.0; 34.8) | 34.7 (34.2; 35.2) | ||
| CHA1197 | Gad− | 33.9 (33.4; 34.3) | 30.4 (29.8; 30.9) | ||
| CHA805-g | AprA− | 33.6 (33.3; 34.0) | 32.7 (32.3; 33.0) | ||
| CHA1241 | Phl− | 28.7 (28.3; 29.1) | 33.0 (32.6; 33.5) | ||
| CHA5091 | Prn− | 28.5 (28.2; 28.9) | 32.7 (32.3; 33.0) | ||
| CHA5092 | Plt− | 28.6 (28.3; 29.0) | 30.8 (30.3; 31.3) | ||
| CHA5101 | Ofa− | 28.2 (27.6; 28.8) | 30.9 (30.3; 31.4) | ||
| CHA5103 | Hcn− | 30.9 (30.5; 31.2) | 35.8 (35.4; 36.2) | ||
| CHA5118 | Phl−Prn−Plt−Hcn−Ofa− | 29.3 (28.9; 29.8) | 32.6 (32.1; 33.1) | ||
| CHA19 | GacS− | 36.0 (35.3; 36.7) | 32.0 (31.5; 32.6) | ||
| CHA89 | GacA− | 32.6 (32.2; 33.1) | 33.8 (33.3; 34.3) | ||
| Control | >40 | >40 | >38 | >38 | |
| CMR12a | Wild type | 26.8 (26.5; 27.0) | 29.2 (28.6; 29.8) | ||
| Clp1 | Ses− | 29.4 (29.1; 29.7) | 34.3 (33.9; 34.7) | ||
| ΔClp2 | Ofa− | 26.4 (26.2; 26.7) | 28.2 (27.8; 28.7) | ||
| ΔClp2-clp1 | Ofa− Ses− | 27.0 (26.7; 27.3) | 30.0 (29.7; 30.4) | ||
| ΔPhz | Phz− | 26.7 (26.5; 27.0) | 29.8 (29.5; 30.2) | ||
| ΔPhz-Clp1 | Phz−Ses− | 28.5 (28.2; 28.7) | 32.0 (31.7; 32.4) | ||
| ΔPhz-ΔClp2 | Phz−Ofa− | 26.1 (25.9; 26.3) | 29.1 (28.6; 29.6) | ||
| ΔPhz-ΔClp2-Clp1 | Phz−Ofa−Ses− | 28.8 (28.4; 29.2) | 31.9 (31.5; 32.3) | ||
| Control | >39 | >39 | |||
| PCL1391 | Wild type | 28.3 (28.0; 28.6) | 29.3 (29.0; 29.7) | 28.9 (28.4; 29.4) | 26.5 (26.2; 26.8) |
| PCL1832 | Clp1391− | 30.0 (29.6; 30.4) | 32.3 (31.8; 32.7) | 31.2 (30.7; 31.4) | 28.3 (27.8; 28.7) |
| PCL1113 | Phz− | 28.8 (28.4; 29.1) | 30.0 (29.6; 30.5) | ||
| PCL1123 | GacS− | 29.2 (28.9; 29.5) | 30.5 (30.0; 31.0) | ||
| PCL5103 | Hcn− | 32.4 (31.8; 33.0) | 27.4 (27.1; 27.8) | ||
| Control | >39 | >39 | >33.5 | >34.5 | |
Lethal time (LT.
significantly faster;
significantly slower. If 50% mortality was not reached by the end of the experiment, LT.
Lethal time 50 (LT.
| CHA0 | Wild type | 24.8 (23.7; 25.8) | 23 (21.8; 24.1) | 20.8 (19.8; 21.8) |
| CHA400 | Pvd− | 26.8 (25.3; 28.2) | 23.6 (22.7; 24.6) | |
| CHA1196 | Gcd− | 21.9 (21.1; 22.7) | 23.6 (22.6; 24.6) | |
| CHA1197 | Gad− | 26.0 (24.9; 27.2) | 23.0 (22.1; 24.0) | |
| CHA805-g | AprA− | 22.1 (21.1; 23.2) | 22.9 (21.8; 24.1) | |
| CHA1241 | Phl− | 24.3 (23.3; 25.4) | 22.9 (21.9; 23.8) | |
| CHA5091 | Prn− | 21.1 (20.0; 22.1) | 20.6 (19.6; 21.7) | |
| CHA5092 | Plt− | 27.1 (25.8; 28.4) | 21.7 (20.8; 22.6) | |
| CHA5098 | Phl−Prn−Plt | 26.4 (25.2; 27.6) | 19.7 (18.7; 20.8) | |
| CHA5101 | Ofa− | 28.9 (27.7; 30.2) | 31.1 (29.3; 32.9) | |
| CHA5103 | Hcn− | 27.8 (26.4; 29.3) | 23.7 (22.8; 24.6) | |
| CHA5118 | Phl−Prn−Plt−Hcn−Ofa− | 31.6 (30.4; 32.7) | 34.6 (32.6; 36.5) | |
| CHA89 | GacA− | >37 | >37 | >37 |
| Control | >37 | >37 | >37 | |
| CMR12a | Wild type | 18.0 (15.6; 20.5) | 21.0 (20.0; 22.0) | |
| Clp1 | Ses− | 31.3 (28.0; 34.7) | 25.8 (23.8; 27.8) | |
| ΔClp2 | Ofa− | 23.5 (21.2; 25.9) | 20.9 (19.7; 22.1) | |
| ΔClp2-clp1 | Ofa−Ses− | 37.3 (32.9; 41.7) | 33.5 (29.2; 37.9) | |
| ΔPhz | Phz− | 21.9 (20.4; 23.5) | 20.8 (18.9; 22.7) | |
| ΔPhz-Clp1 | Phz−Ses− | 24.0 (22.3; 25.7) | 35.1 (31.5; 38.6) | |
| ΔPhz-ΔClp2 | Phz−Ofa− | 20.1 (17.6; 22.6) | 27.9 (26.3; 29.5) | |
| ΔPhz-ΔClp2-Clp1 | Phz−Ofa−Ses− | 37.2 (33.5; 40.9) | 30.7 (27.7; 33.7) | |
| Control | >42 | >42 | ||
| PCL1391 | Wild type | 17.1 (15.7; 18.5) | 20.9 (19.2; 22.5) | 27.9 (25.4; 30.5) |
| PCL1832 | Clp1391− | 21.2 (19.4; 23.0) | 23.9 (21.5; 26.2) | |
| PCL1113 | Phz− | 19.5 (18.1; 20.9) | 19.9 (18.1; 21.7) | |
| PCL1123 | GacS− | 37.6 (34.1; 41.2) | 34.0 (29.3; 38.8) | |
| PCL5103 | Hcn− | 22.9 (21.7; 24.2) | 30.9 (28.4; 33.4) | |
| Control | >42 | >42 | >42 | |
Lethal time (LT.
significantly faster;
significantly slower; If 50% mortality was not reached by the end of the experiment, LT.
Figure 1Hydrogen cyanide-deficient mutants exhibit reduced injectable insecticidal activity. (A,B) Injectable activity against Galleria mellonella. Thirty larvae per treatment were injected with 2 × 103 bacterial cells and survival was recorded hourly. (C,D) Oral activity against Plutella xylostella. For Pseudomonas protegens CHA0 (C) 64 larvae were exposed to artificial diet inoculated with 4 × 106 bacterial cells and for Pseudomonas chlororaphis PCL1391 (D) 32 larvae were exposed to 2 × 107 bacterial cells. Sterile 0.9% NaCl solution served as control. Treatments that differed significantly from their respective wild-type strain (Log-Rank test p ≤ 0.05, Survival Package in R) are marked with an asterisk. This figure shows the survival curves of one representative experiment per strain and insect system. The LT50 values corresponding to these experiments and to a repetition of them are depicted in Tables 2, 3. Solid black line, wild-type strain; dotted blue line, mutants deficient for hydrogen cyanide production (Hcn−, CHA5103, PCL5103); dash-dot green line, 0.9% NaCl solution control.
Figure 2Cyclic lipopeptides contribute to insecticidal activity of three plant-beneficial pseudomonads. (A,B,C) Injectable activity against Galleria mellonella. 30 larvae per treatment were injected with 2 × 103 bacterial cells and survival was recorded hourly. (D,E,F) Oral activity against Plutella xylostella. For Pseudomonas protegens CHA0 (D) 64 larvae were exposed to artificial diet inoculated with 4 × 106 bacterial cells. In experiments with strains Pseudomonas chlororaphis PCL1391 (E) and Pseudomonas sp. CMR12a (F) 32 larvae were exposed to diet inoculated with 2 × 107 bacterial cells. Sterile 0.9% NaCl solution served as control. Treatments that differed significantly from their respective wild-type strain (Log-Rank test p ≤ 0.05, Survival Package in R) are marked with an asterisk. This figure shows the survival curves of one representative experiment per strain and insect system. The LT50 values corresponding to these experiments and to a repetition of them are depicted in Tables 2, 3. Solid black line, wild-type strain; dashed red line, mutants deficient for orfamide production (Ofa−, CHA5101, CMR12a-ΔClp2), dashed pink line, mutant deficient for Clp1391 production (Clp1391−, PCL1832), dotted purple line, mutant deficient for sessilin production (Ses−, CMR12a-Clp1); dashed gray line, double mutant deficient for sessilin and orfamide production (Ses−Ofa−, CMR12a-ΔClp2-Clp1); dash-dot light blue line, triple mutant deficient for sessilin, orfamide and phenazine production (Ses−Ofa−Phz−, CMR12a-ΔPhz-ΔClp2-Clp1); dash-dot green line, 0.9% NaCl solution control.
Expression of biosynthetic genes for antifungal metabolites during insect infection by .
| 20 h | 3 | 3 | 0 | 0 | 3 | 0 | 3 | 1 | 2 | 2 | 3 | 1 | 3 | 1 |
| 30 h | 3 | 3 | 3 | 2 | 2 | 0 | 3 | 3 | 2 | 3 | 3 | 2 | 3 | 1 |
| Dead | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Galleria mellonella larvae were infected systemically by injection (i) of 2 × 10.
Figure 3Overview of exoproducts and cell surface components contributing to the antimicrobial and insecticidal activity of bacteria of the . Compounds involved in activity against both microorganisms as well as insects are depicted in red. AprA; protease AprA; ChiC, chitinase C; Clp, cyclic lipopeptide; Fit, P. fluorescens insecticidal toxin; Gcd, Glucose dehydrogenase; Hcn, hydrogen cyanide; O-PS, O-antigen polysaccharide; Phl, 2,4-diacetylphloroglucinol; Phz, phenazine; PlcN, phospholipase C; Plt, pyoluteorin; Prn, pyrrolnitrin; Rzx, rhizoxin.